Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer immunology and immunotherapy in 2024, which are listed below:

1. “Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations”
by Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti and Antonello Veccia
Cancers 2024, 16(7), 1440; https://doi.org/10.3390/cancers16071440
Available online: https://www.mdpi.com/2072-6694/16/7/1440

2. “Syngeneic Mouse Models for Pre-Clinical Evaluation of CAR T Cells”
by Eman N. Ahmed, Lauren C. Cutmore and John F. Marshall
Cancers 2024, 16(18), 3186; https://doi.org/10.3390/cancers16183186
Available online: https://www.mdpi.com/2072-6694/16/18/3186

3. “T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies”
by Paweł Cech, Katarzyna Skórka, Laura Dziki and Krzysztof Giannopoulos
Cancers 2024, 16(8), 1580; https://doi.org/10.3390/cancers16081580
Available online: https://www.mdpi.com/2072-6694/16/8/1580

4. “Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting”
by Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli and Giuseppe Curigliano
Cancers 2024, 16(2), 281; https://doi.org/10.3390/cancers16020281
Available online: https://www.mdpi.com/2072-6694/16/2/281

5. “Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer”
by Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J. Raftery and Gabriele Pecher
Cancers 2024, 16(2), 388; https://doi.org/10.3390/cancers16020388
Available online: https://www.mdpi.com/2072-6694/16/2/388

6. “MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC)”
by Qiulin Wu, Xicai Li, Yan Yang, Jingquan Huang, Ming Yao, Jianjun Li, Yubin Huang, Xiaoyong Cai, David A. Geller and Yihe Yan
Cancers 2024, 16(2), 269; https://doi.org/10.3390/cancers16020269
Available online: https://www.mdpi.com/2072-6694/16/2/269

7. “Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer”
by Ramya Ayyalasomayajula and Mare Cudic
Cancers 2024, 16(7), 1334; https://doi.org/10.3390/cancers16071334
Available online: https://www.mdpi.com/2072-6694/16/7/1334

8. “Impact of Nutritional Status on Neutrophil-to-Lymphocyte Ratio as a Predictor of Efficacy and Adverse Events of Immune Check-Point Inhibitors”
by Masahiko Sue, Yasuto Takeuchi, Shoichiro Hirata, Akinobu Takaki and Motoyuki Otsuka
Cancers 2024, 16(10), 1811; https://doi.org/10.3390/cancers16101811
Available online: https://www.mdpi.com/2072-6694/16/10/1811

9. “Checkpoint Inhibitors in Dogs: Are We There Yet?”
by Antonio Giuliano, Pedro A. B. Pimentel and Rodrigo S. Horta
Cancers 2024, 16(11), 2003; https://doi.org/10.3390/cancers16112003
Available online: https://www.mdpi.com/2072-6694/16/11/2003

10. “The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic Implications”
by Adam Merenstein, Loiy Obeidat, Apostolos Zaravinos and Benjamin Bonavida
Cancers 2024, 17(1), 19; https://doi.org/10.3390/cancers17010019
Available online: https://www.mdpi.com/2072-6694/17/1/19

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office